Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27Lymphoma, Large B-Cell, Diffuse 26Burkitt Lymphoma 20Lymphoma, Follicular 14Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Neoplasms 7Lymphoma, B-Cell 6Recurrence 5Prostatic Neoplasms, Castration-Resistant 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, B-Cell, Marginal Zone 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Ovarian Neoplasms 3Lymphoproliferative Disorders 3Hodgkin Disease 3Prostate Cancer Metastatic 2Multiple Myeloma 2Metastatic Castration-resistant Prostate Cancer 2Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Leukemia 2Immunoblastic Lymphadenopathy 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Specimen Handling 45pembrolizumab 41Biopsy 37Magnetic Resonance Spectroscopy 35Nivolumab 21Paclitaxel 20Gemcitabine 20Radiosurgery 19Carboplatin 19Irinotecan 14Ipilimumab 13Cisplatin 12Capecitabine 12130-nm albumin-bound paclitaxel 12Taxes 11Pemetrexed 11trastuzumab deruxtecan 10olaparib 10Leucovorin 10Fluorouracil 10Oxaliplatin 9Fulvestrant 9Cyclophosphamide 9Cetuximab 9durvalumab 8abemaciclib 8X-Rays 8Drug Therapy 8Bevacizumab 8palbociclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Prednisone × 90 days × Clear all
NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡